Autologous Serum Eye Drops in Dry Eye Syndrome: Clinical Efficacy and Safety Evaluation
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This study aims to evaluate the clinical efficacy and safety of autologous serum eye drops (ASEDs) in patients with moderate-to-severe dry eye syndrome who are refractory to conventional artificial tear therapy.
Eligibility
Participation Requirements
Sex: All
Maximum Age: 18
Healthy Volunteers: f
View:
• Children aged less than 18 years.
• Both sexes.
• Diagnosed with moderate to severe dry eye syndrome (DES) refractory to artificial tears.
Locations
Other Locations
Egypt
The General Authority for Teaching Hospitals and Institutes
RECRUITING
Cairo
Contact Information
Primary
Hossam A Hassan, MD
Dr.hossameabdalfataah@gothi.gov.eg
00201026808348
Time Frame
Start Date: 2025-09-01
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 70
Treatments
Experimental: Study group
Participants will receive eye drops prepared from their blood serum following a standardized protocol. Specifically, 40 mL of venous blood was collected from each participant at the start of the study and centrifuged at 3000 rpm for 15 min.
Related Therapeutic Areas
Sponsors
Leads: The General Authority for Teaching Hospitals and Institutes